WorldCat Identities

Pillonel, Josiane

Overview
Works: 7 works in 8 publications in 2 languages and 16 library holdings
Roles: Redactor, Author, Other, Contributor
Publication Timeline
.
Most widely held works by Josiane Pillonel
Surveillance épidémiologique des donneurs de sang homologues en France entre 1992 et 2002 by Josiane Pillonel( Book )

2 editions published in 2004 in French and held by 5 WorldCat member libraries worldwide

HCV and HBV prevalence based on home blood self-sampling and screening history in the general population in 2016: contribution to the new French screening strategy by the 2016 Health Barometer Group( )

1 edition published in 2019 in English and held by 2 WorldCat member libraries worldwide

HIV Prevalence and Sexual Risk Behaviors Associated with Awareness of HIV Status Among Men Who Have Sex with Men in Paris, France by Annie Velter( )

1 edition published in 2012 in English and held by 2 WorldCat member libraries worldwide

Rapid and large-scale implementation of HCV treatment advances in France, 2007-2015 by Cécile Brouard( )

1 edition published in 2017 in English and held by 2 WorldCat member libraries worldwide

Surveillance of perinatal AIDS and HIV diagnoses in France by Florence Lot( )

1 edition published in 2008 in English and held by 2 WorldCat member libraries worldwide

Contribution à l'étude du phénomène de l'alcoolisation by Josiane Pillonel( )

1 edition published in 1983 in French and held by 2 WorldCat member libraries worldwide

Revealing geographical and population heterogeneity in HIV incidence, undiagnosed HIV prevalence and time to diagnosis to improve prevention and care: estimates for France( )

1 edition published in 2018 in English and held by 1 WorldCat member library worldwide

Abstract: Introduction: To close gaps in HIV prevention and care, knowledge about locations and populations most affected by HIV is essential. Here, we provide subnational and sub-population estimates of three key HIV epidemiological indicators, which have been unavailable for most settings. Methods: We used surveillance data on newly diagnosed HIV cases from 2004 to 2014 and back-calculation modelling to estimate in France, at national and subnational levels, by exposure group and country of birth: the numbers of new HIV infections, the times to diagnosis, the numbers of undiagnosed HIV infections. The denominators used for rate calculations at national and subnational levels were based on population size (aged 18 to 64) estimates produced by the French National Institute of Statistics and Economic Studies and the latest national surveys on sexual behaviour and drug use. Results: We estimated that, in 2014, national HIV incidence was 0.170 (95% confidence intervals (CI): 0.16 to 0.18) or 6607 (95% CI: 6057 to 7196) adults, undiagnosed HIV prevalence was 0.640 (95% CI: 0.57 to 0.70) or 24, 197 (95% CI: 22, 296 to 25, 944) adults and median time to diagnosis over the 2011 to 2014 period was 3.3years (interquartile range: 1.2 to 5.7). Three mainland regions, including the Paris region, out of the 27 French regions accounted for 56% of the total number of new and undiagnosed infections. Incidence and undiagnosed prevalence rates were 2- to 10-fold higher than the national rates in three overseas regions and in the Paris region (p -values<0.001). Rates of incidence and undiagnosed prevalence were higher than the national rates for the following populations (p -values<0.001): born-abroad men who have sex with men (MSM) (respectively, 108- and 78-fold), French-born MSM (62- and 44-fold), born-abroad persons who inject drugs (14- and 18-fold), sub-Saharan African-born heterosexuals (women 15- and 15-fold, men 11- and 13-fold). Importantly, affected populations varied from one region to another, and in regions apparently less impacted by HIV, some populations could be as impacted as those living in most impacted regions. Conclusions: In France, some regions and populations have been most impacted by HIV. Subnational and sub-population estimates of key indicators are not only essential to adapt, design implement and evaluate tailored HIV interventions in France, but also elsewhere where similar heterogeneity is likely to exist
 
Audience Level
0
Audience Level
1
  Kids General Special  
Audience level: 0.95 (from 0.88 for Revealing ... to 0.97 for Surveillan ...)

Languages